Complex Cardiovascular Catheter Therapeutics (C3)
Avatar

What are the Major Pharmacodynamic and Safety Differences Between Antiplatelet Therapies? Absorption, Antidotes, Onset of Action, Degree of Platelet Inhibition and Reversibility

By Complex Cardiovascular Catheter Therapeutics (C3) FEATURING Sandeep Nathan
By Complex Cardiovascular Catheter Therapeutics (C3) FEATURING Sandeep Nathan
0 views
April 26, 2016
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
15:40
ACC 2022 Conference Coverage

ACC 2022: Triple Therapy - When to Use and How Long

Feat. D. Kumbhani
28:11
Top Ten Topics in Clinical Cardiology 2021

Time to Retire Aspirin?

Feat. R. Mehran
11:26
Houston Methodist DeBakey Heart and Vascular Center

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Feat. M. Miedema
31:10
Insights from 2024 ACP Annual Meeting

ACP 2024 Insights: Acute Coronary Syndromes - Evaluation, Diagnosis …

Feat. D. Berg
21:51
Cedars Sinai

Treating Stenosis or Ischemia Does Not Improve Outcomes: Medical The…

Feat. W. Boden
07:10
American College of Cardiology

Ticagrelor with or without Aspirin in ACS after PCI (TICO)

Feat. P. Block, Y. Jang
17:49
CHEST 2022 Coverage

Perioperative Management of Antithrombotic Therapy

Feat. J. Douketis
11:07
Houston Methodist DeBakey Heart and Vascular Center

Aspirin & Primary Prevention: What Do the Guidelines Say?

Feat. M. Gulati
09:14
American College of Cardiology

MASTER DAPT: Dual Antiplatelet Therapy After PCI in Patients at High…

Feat. V. Fuster, D. Itchhaporia, M. Mack, C. Albert, J. Grapsa
14:20
ARCH Advanced Revascularization Symposium

Highlights and Critiques of ACC/AHA/SCAI Revascularization Guidelines

Feat. D. A. Cox
20:06
Canadian Collaborative Research Network

Stable CAD: ASA Alone, Prolonged DAPT or Low-Dose Rivaroxaban?

Feat. M. Sabatine
57:14
Northwestern Medicine Cardiovascular Care

Stress Testing in the Real World

Feat. M. Eimer
12:46
AHA 2022 Conference Coverage

AHA 2022 Debate: Should CABG Be Level IIB for Improving Survival Com…

Feat. F. Bakaeen
25:26
The Texas Heart Institute

The Use of Coronary Artery Calcium Score to Determine Benefit of Asp…

Feat. E. Hernandez
15:13
Cardiometabolic Health Congress (CMHC)

Dual Pathway Inhibition in the Cardiometabolic Patient: How Effectiv…

Feat. D. Bhatt
37:35
Top Ten Topics in Clinical Cardiology 2022

Top 10 Coronary Interventional Trials of 2022

Feat. S. Sharma
16:34
AHA 2022 Conference Coverage

AHA 2022: Bivalirudin With a Post-PCI High-Dose Infusion versus Hepa…

Feat. G. W. Stone
12:53
Scottsdale Interventional Forum 2018

What is the Optimal DAPT Duration?

Feat. R. Yeh
08:07
Houston Methodist DeBakey Heart and Vascular Center

Anti Platelet Therapy Clinical Case Discussion: Q&A with Dr. Nea…

Feat. N. Kleiman
13:36
Houston Methodist DeBakey Heart and Vascular Center

Plaque, Thrombosis and Bleeding Risk: Use of Antiplatelet Therapy

Feat. J. Ferreiro